Next Article in Journal
Effects of Capsinoids on Daily Physical Activity, Body Composition and Cold Hypersensitivity in Middle-Aged and Older Adults: A Randomized Study
Next Article in Special Issue
Protein-Related Dietary Parameters and Frailty Status in Older Community-Dwellers across Different Frailty Instruments
Previous Article in Journal
Modeling Possible Outcomes of Updated Daily Values on Nutrient Intakes of the United States Adult Population
Previous Article in Special Issue
Vitamin D Deficiency and Sarcopenia in Older Persons

Sarcopenia and Heart Failure

Department of Translational Medical Sciences, University of Naples Federico II Naples, 80131 Naples, Italy
Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy
IRCCS Salvatore Maugeri Foundation, Scientific Institute of Veruno, 28010 Novara, Italy
Department of Systems Medicine, University of Rome Tor Vergata, 00100 Rome, Italy
San Raffaele Roma Open University, School of Medicine, 00100 Rome, Italy
Division of Internal Medicine, AOU San Giovanni di Dio e Ruggi di Aragona, 84121 Salerno, Italy
Department of Geriatrics, Neurosciences and Orthopedics, Catholic University of the Sacred Heart, 00100 Rome, Italy
Author to whom correspondence should be addressed.
Nutrients 2020, 12(1), 211;
Received: 5 December 2019 / Revised: 25 December 2019 / Accepted: 8 January 2020 / Published: 14 January 2020
(This article belongs to the Special Issue Sarcopenia and Nutritional Status)
Modifications of lean mass are a frequent critical determinant in the pathophysiology and progression of heart failure (HF). Sarcopenia may be considered one of the most important causes of low physical performance and reduced cardiorespiratory fitness in older patients with HF. Sarcopenia is frequently misdiagnosed as cachexia. However, muscle wasting in HF has different pathogenetic features in sarcopenic and cachectic conditions. HF may induce sarcopenia through common pathogenetic pathways such as hormonal changes, malnutrition, and physical inactivity; mechanisms that influence each other. In the opposite way, sarcopenia may favor HF development by different mechanisms, including pathological ergoreflex. Paradoxically, sarcopenia is not associated with a sarcopenic cardiac muscle, but the cardiac muscle shows a hypertrophy which seems to be “not-functional.” First-line agents for the treatment of HF, physical activity and nutritional interventions, may offer a therapeutic advantage in sarcopenic patients irrespective of HF. Thus, sarcopenia is highly prevalent in patients with HF, contributing to its poor prognosis, and both conditions could benefit from common treatment strategies based on pharmacological, physical activity, and nutritional approaches. View Full-Text
Keywords: sarcopenia; heart failure; elderly; cachexia; malnutrition; physical activity sarcopenia; heart failure; elderly; cachexia; malnutrition; physical activity
Show Figures

Figure 1

MDPI and ACS Style

Curcio, F.; Testa, G.; Liguori, I.; Papillo, M.; Flocco, V.; Panicara, V.; Galizia, G.; Della-Morte, D.; Gargiulo, G.; Cacciatore, F.; Bonaduce, D.; Landi, F.; Abete, P. Sarcopenia and Heart Failure. Nutrients 2020, 12, 211.

AMA Style

Curcio F, Testa G, Liguori I, Papillo M, Flocco V, Panicara V, Galizia G, Della-Morte D, Gargiulo G, Cacciatore F, Bonaduce D, Landi F, Abete P. Sarcopenia and Heart Failure. Nutrients. 2020; 12(1):211.

Chicago/Turabian Style

Curcio, Francesco, Gianluca Testa, Ilaria Liguori, Martina Papillo, Veronica Flocco, Veronica Panicara, Gianluigi Galizia, David Della-Morte, Gaetano Gargiulo, Francesco Cacciatore, Domenico Bonaduce, Francesco Landi, and Pasquale Abete. 2020. "Sarcopenia and Heart Failure" Nutrients 12, no. 1: 211.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop